Applied Therapeutics Inc. announced the appointment of Mark Vignola as Chief Financial Officer. Dr. Vignola brings extensive experience in capital markets and finance in the life sciences industry to Applied Therapeutics, serving most recently as Head of Corporate Development & Investor Relations at Intercept Pharmaceuticals and, prior to Intercept, as an equity research associate at Needham & Company. He joins Dr. Riccardo Perfetti, MD, PhD, who was appointed Chief Medical Officer of Applied in 2018.